DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: docetaxel

Summary for Generic Name: docetaxel

Tradenames:3
Patents:1
Applicants:8
NDAs:8
Drug Master File Entries: see list37
Suppliers: see list8

Pharmacology for Ingredient: docetaxel

Drug ClassMicrotubule Inhibitor
Physiological EffectMicrotubule Inhibition

Clinical Trials for: docetaxel

Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events
Status: Completed Condition: CYP3A Phenotyping; CYP3A5 and MDR1 Genotyping; Docetaxel Toxicity; Associations Between Genetic Data and Docetaxel Toxicity

Randomized Study of Docetaxel +/- ZD6474 in Metastatic TCC
Status: Completed Condition: Transitional Cell Carcinoma; Bladder Cancer

Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer
Status: Completed Condition: Advanced Solid Cancers

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer
Status: Recruiting Condition: Hormone Refractory Prostate Cancer

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
Status: Completed Condition: Nausea and Vomiting, Chemotherapy-Induced; Cancer

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients
Status: Recruiting Condition: Breast Cancer

A Phase 1b Dose Escalation Trial of PSKĀ®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer
Status: Suspended Condition: Prostatic Neoplasms

Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
Status: Terminated Condition: Non-Small Cell Lung Cancer

Docetaxel and Lycopene in Metastatic Castration-resistant Prostate Cancer
Status: Recruiting Condition: Adenocarcinoma of the Prostate

RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
Status: Terminated Condition: Breast Cancer

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sun Pharma Global
DOCEFREZ
docetaxel
INJECTABLE;INJECTION022534May 3, 2011RXYes<disabled>
Accord Hlthcare
DOCETAXEL
docetaxel
INJECTABLE;INJECTION201195Jun 8, 2011RXNo<disabled>
Accord Hlthcare
DOCETAXEL
docetaxel
INJECTABLE;INJECTION201195Apr 20, 2012RXNo<disabled>
Accord Hlthcare
DOCETAXEL
docetaxel
INJECTABLE;INJECTION201195Apr 20, 2012RXYes<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc